Phase 1 biotech developing selected TIL therapies for solid tumors.
Industry: Health Care
Latest Trade: $0.48 +0.01 (+1.8%)
First Day Return: -8.3%
Return from IPO: -96.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/12/2023 |
Offer Price | $12.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 6.7 |
Deal Size ($mm) | $80 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/20/2023 |
Offer Price | $12.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 6.7 |
Deal Size ($mm) | $80 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | La Jolla, CA, United States |
Founded | 2015 |
Employees at IPO | 108 |
Website www.turnstonebio.com |